Latest Breaking News On - Frederic chereau - Page 7 : vimarsana.com

LogicBio Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update - First patient for Phase 1/2 SUNRISE trial expected to be enrolled in early 2021 -Translational preclinical data for sAAVy platform shows substantial improvements over liver tropic capsids used in gene therapy programs to date -New Chief Scientific and Chief Financial Officers recently added to Executive Team News provided by Share this article Share this article LEXINGTON, Mass., March 15, 2021 /PRNewswire/  LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a clinical- stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today reported financial results for the year ended December 31, 2020 and provided a business update.

United statesAdam daleyCecilia jonesFrederic chereauMariana nachtChildren medical research institute of australiaLogicbio therapeutics incExchange commissionCompany annual report on formGilmartin groupBerry company public relationsCompany quarterly report on formLogicbio therapeuticsMedical research instituteLogicbio milestonesMonths ended december